Our sole focus is to help our customers stay ahead of the competition and anticipate changes in pharmaceutical marketing quickly.
Orange, CA (PRWEB) November 30, 2010
PharmaVoxx, a leading provider of competitor intelligence and business analytics for pharmaceutical marketing, today announced that it has been selected by Med Ad News as one of three "Pharmaceutical Marketing Ventures to Watch" in 2010.
"It is an honor to be recognized by a leading industry publication like Med Ad News," said Dao Vo, General Manager at PharmaVoxx. "Our sole focus is to help our customers stay ahead of the competition and anticipate changes in pharmaceutical marketing quickly. A glowing acknowledgment like this confirms that we are living up to our vision of being the innovative leader in competitive analysis."
This is the fourth year that Med Ad News has named the list of top Pharmaceutical Marketing Ventures to Watch. Only three companies, including PharmaVoxx, were chosen from dozens of nominations.
One of the reasons for the industry notice recently is that PharmaVoxx aggressively evolved new product offerings to meet the changing digital demands of customers. In 2009, PharmaVoxx expanded its competitor intelligence database of promotional materials to include digital media and e-promotions. In 2010, PharmaVoxx added pharmaceutical television advertising and online video monitoring in its database.
The full article, "Ad-ventures in Marketing VI" is featured in the November/December 2010 issue of Med Ad News, and is available to online subscribers at http://www.pharmalive.com/magazines/medad.
PharmaVoxx delivers highly specific, summarized intelligence of pharmaceutical messaging and promotional strategies. More than an online library of marketing materials, PharmaVoxx gives marketing and competitive intelligence managers a full suite of solutions to track-and-analyze competitor promotional activities. For more information, visit http://www.pharmavoxx.com.